LpMab-12 established by CasMab technology specifically detects sialylated o-glycan on Thr52 of platelet aggregation-stimulating domain of human podoplanin
Dive into the research topics of 'LpMab-12 established by CasMab technology specifically detects sialylated o-glycan on Thr52 of platelet aggregation-stimulating domain of human podoplanin'. Together they form a unique fingerprint.